Tezspire 210 MG/1.91 ML syring 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FRWD0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,123
Award facts
- Contract value 100% obligated
- $28,123.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,123.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger procurement vehicle supporting federal medical supply needs.
This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Tezspire is a specialty biologic medication used in the treatment of severe asthma, reflecting the company's role as a critical vendor delivering specialized pharmaceuticals to support Department of Defense and federal healthcare systems. AmerisourceBergen's consistent performance on DLA contracts demonstrates its capability to fulfill complex federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FRWD0?
SPE2DB25FRWD0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FRWD0 worth?
The government has obligated $28,123 on SPE2DB25FRWD0.
Is contract SPE2DB25FRWD0 an order under another contract?
Yes. SPE2DB25FRWD0 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRWD0 competed?
The extent of competition for SPE2DB25FRWD0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award